The aberrant over-expression and proliferative roles of the TRPM7 and TRPM8 ion channels in pancreatic adenocarcinoma suggest a unique opportunity of their development as clinical biomarkers and therapeutic targets (Figure 5). Here, TRPM7 is linked to pancreatic adenocarcinoma.